NOVILYTIC

Protecting and securing lifesaving drugs is Novilytic’s mission. We accomplish this via the disruptive use of nanotechnology and cutting-edge science designed for Process R&D and pharmaceutical manufacturing. The company’s flagship instrument is The Proteometer, a device that for drug development companies that can provide real-time warnings on molecular structure changes. Like in the old coal mines, the Proteometer thus becomes “The Canary in The Fermentor.” Adoption of this revoluti... onary technology will be enhanced by utilizing the common Liquid Cromatograph, or “LC”. Novilytic’s patented kit technology allows customers to convert their LC into a Proteometer in less than one hour. Training, software, and service all remain the same – thus ensuring the ease of use and speed of adoption. Commercialization efforts are underway as the organization is preparing for a Fall 2022 launch of the following reagents, columns, and modules: Sequstron™ & Luminon™ Columns and Reagents Water-based nanotechnology in development for Pharmaceutical Process Chemists who need fast molecular structure recognition of Critical Quality Attributes. Unlike common LC and MS methods, both technologies measure proteoforms in-line, saving hours of time and reducing purification costs. Proteometer™ Kits The Novilytic Proteometer™ is an instrument for Pharmaceutical Process Chemists who need to develop improved CQA analysis. Unlike common yet archaic monitoring technologies, the Proteometer does in-line monitors molecular structure in real time providing better data for controlling reactions. This technology will effectively turn traditional LCs into Proteometers. Our talented team includes 5 Ph.D. chemists and engineers who have helped us secure significant patents and other IP.